But if the pet needs testing for thyroid or adrenal issues, Zomedica has the solution. The applications of Truforma are limited to the immunodiagnostics sub-market, which isnt the fastest-growing submarket molecular diagnostics is. These cookies will be stored in your browser only with your consent. The technology is a high-precision solution presently being used to deliver cleaner signals in communications materials particularly the next-gen 5G-enabled devices. Yes, the prospects of Truforma are truly eye-popping. Delivery Schedule means the schedule for the delivery of Services as set forth in attached Annex 3.. Proforma means producing a balance sheet that reflects a reasonably accurate financial statement of the Failed bank through the date of closing. Zomedica Appoints New Chief Financial Officer, Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity Revenue up 361% from 2021 through combination of acquisitions and organic growth, Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15, Zomedica Corp. Diagnostics Initiation Report, Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022, Zomedica to Participate in the Lytham Partners Investor Select Conference, Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies, Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors, Zomedica to Present at Sidoti Virtual Investor Conference January 18-19, Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans. Its not a pretty picture if youre trying to get a handle on where this companys shares are going to go next. Necessary cookies are absolutely essential for the website to function properly. Upon successfully completing this verification and development work, Zomedica intends to commercialize all five initial assays in select strategic markets. The first official purchaser of a TRUFORMA system was Jason Berg, DVM, DACVIM, founder and president of Guardian Veterinary Specialists, a 29,000-square-foot advanced emergency critical care and specialty hospital in Brewster, New York. If the pets are healthy, that doesnt help Zomedica. Heck, the stock was even flogged on Cameo by a celebrity. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. PCG is not a registered or licensed broker, dealer, broker-dealer, investment adviser nor investment manager, nor does PCG engage in any activities that would require such registrations. Zomedica (ZOM) hasadded ~8.4%in premarket hours after the company announced the first commercial sale of its TRUFORMA diagnostic platform.With the instrument and three of five of. Article printed from InvestorPlace Media, https://investorplace.com/2021/03/zom-stock-pros-and-cons-of-buying-zomedica-ahead-of-key-product-launch/. By the middle of last summer, it was clear that the surge that happened in March was becoming a full-fledged boom. Heres a look at the pros and cons of buying ZOM stock. The analysis tested more than 100 samples across 700 cartridge runs using cartridges produced across numerous manufacturing lots. 3 Stocks That Are Poised to Plunge. Copyright Its a wait-and-see kind of situation. Commercialization plans remain on track and we are beginning to . American Consumer News, LLC dba MarketBeat 2010-2023. Forward-looking information is based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. That market is expected to reach roughly $2.7 billion by 2027, with a cumulative average growth rate of 4.1% from 2020 to 2027. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. 100 Phoenix DriveSuite 125Ann Arbor, MI 48108, General inquiries: info@zomedica.comInvestor inquiries: investors@zomedica.com, Privacy Notice | Terms of Use | Supplier Terms & Conditions | Minimum Advertised Pricing | Customer Terms & Conditions | Forward Looking Statements. As a vet myself, I know the value of such a product to a veterinary practice. 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher, Proterra Inc., A Penny Stock To Put On The Watchlist, Buffett Reduces Taiwan Semiconductor Stake After This Happened, Nio Inc - (NYSE:NIO) Shares Sold by National Bank of Canada FI, Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, Why Restaurant Stocks are the Stocks to Buy Right Now, View 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, View Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher, View Proterra Inc., A Penny Stock To Put On The Watchlist, View 3 Healthcare Stocks Insiders Are Buying, View Buffett Reduces Taiwan Semiconductor Stake After This Happened, View Nio Inc - (NYSE:NIO) Shares Sold by National Bank of Canada FI. Zomedica took advantage of the run up in price to issue more shares, bringing $173.5 million in cash. Thus, the TRUFORMA canine TSH assay showed a high correlation (R = 0.99) to the Siemens IMMULITE Canine TSH assay. Included in their research and development activities, Zomedica screened 25 monoclonal antibodies pairs to determine an antibody pair with optimum performance for canine and feline testing. Benzinga does not provide investment advice. contact@marketbeat.com This is a small-cap company in the business of delivering point-of-care pet diagnostics. The companion animal business at Zoetis bought in roughly $3.65 billion in 2020 representing over 50% of the companys overall revenue. Get Out Now. Adoption risks: As mentioned earlier, the short-to-mid-term future of Zomedica depends on the success of Truforma. Investor Relations Contact: PCG Advisory Kirin Smith, Presidentksmith@pcgadvisory.com+1 646.823.8656, Plus500. The launch of the TRUFORMA platform is nearing. The dynamic range of the canine TRUFORMA cortisol assay is 0.35-24.0 g/dL compared to the Siemens IMMULITE Cortisol assay dynamic range of 1-50 g/dL. This website uses cookies to improve your experience while you navigate through the website. If you are attending as part of a diocese or institution registration, follow links for individual registrations above . Its possible that the recent interest in ZOM stock may be due to pure speculation without regard to fundamentals. 3 Stocks That Are Poised to Plunge. Assay performance metrics to determine specificity and sensitivity were determined with the goal of meeting or exceeding the stringent testing standards found in a reference lab setting. The potentially revolutionary TRUFORMA diagnostic device is smaller than a desktop printer and is designed to provide highly sensitive, species-optimized initial assays for the diagnosis of thyroid disease in dogs and cats, and adrenal disease in dogs. Necessary cookies are absolutely essential for the website to function properly. Real-time analyst ratings, insider transactions, earnings data, and more. The information contained on this may be Paid Advertising for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the Securities Act). That said, ZOM stock is at best a watchlist candidate at the moment. Its hard to come by the exact figures of how much Zomedicas competitors make in the companion animal diagnostics market. Nasdaq In his latest feat, Louis discovered the Master Key to profiting fromthe biggest tech revolution of this (or any) generation. Reader AdvisoryExcept for statements of historical fact, this news release contains certain "forward-looking information" or forward-looking statements (collectively, forward-looking information) within the meaning of applicable securities law. (Almost) Everything You Need To Know About The EV Market. 2023 InvestorPlace Media, LLC. He received his DVM degree from Texas A&M University and went on to complete his internship and residency training in veterinary neurology and internal medicine at The AnimalMedical Center in New York City, receiving board certification in neurology in 2000 and in internal medicine in 2002. Certain cut-off values in the prediction of outcome in puppies with parvoviral diarrhea is discussed. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. 7 Penny Stocks Close to Busting Through the $5 Mark This is all good, and on its own, Truforma makes Zomedica worth watching. However, I find those conclusions misleading. We also use third-party cookies that help us analyze and understand how you use this website. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: uncertainty as to whether our strategies and business plans will yield the expected benefits; uncertainty as to the timing and results of development work and verification and validation studies; uncertainty as to the timing and results of commercialization efforts; uncertainty as to our ability to supply equipment and assays in response to customer demand; uncertainty as to the likelihood and timing of any required regulatory approvals, availability and cost of capital; the ability to identify and develop and achieve commercial success for new products and technologies; veterinary acceptance of our products; competition from related products; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology and changes in laws and regulations; our ability to secure and maintain strategic relationships; performance by our strategic partners of our obligations under our commercial agreements, including product manufacturing obligations; risks pertaining to permits and licensing, intellectual property infringement risks, risks relating to any required clinical trials and regulatory approvals, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other risk factors disclosed in our filings with the SEC and under our profile on SEDAR at www.sedar.com. It certainly is a pleasure to be able to deliver such good news for our shareholders, employees, partners and, especially, the veterinarians whom we serve, commented Robert Cohen, Interim Chief Executive Officer of Zomedica. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on and Zomedica wasn't on the list. And a successful launch may do just that. Intensive verification of the TRUFORMA TSH assay was conducted on-site at Qorvo Biotechnologies, LLC, QRVO in two different facilities. With the instrument and three of five of the initial assays available for sale, the decision was made to initiate the commercial launch of TRUFORMA ahead of the previously disclosed March 30th schedule. Investor Relations Contact: PCG Advisory GroupKirin Smith, COOksmith@pcgadvisory.com+1 646.863.6519. January 18-20, 2022. Flexible use cases: At launch, the Truforma would support tests for adrenal and thyroid disorders in cats and dogs. The feasibility and design phases of the TRUFORMA ACTH assay have been completed, with verification expected to begin in the near future. That might be where Id look to get in. TRUFORMA canine and feline assays were evaluated and compared with those of the predicate industry gold standard. Readers are cautioned not to place undue reliance on forward-looking information. Adrenal and thyroid conditions have been reported as one of the common conditions in felines and canines. TRUFORMA is the company's innovative diagnostic tool that aims to replace old-fashioned methods of diagnosis that require patient samples to be sent to an outside lab for testing before therapeutic or prescription treatments can be offered. Before you consider Zomedica, you'll want to hear this. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Zomedica pointed to dynamic range as being another critical factor in favor of its TRUFORMA device. For more information, visit www.ZOMEDICA.com. However, as Ill discuss below, while Truforma is a truly exciting product, there are a lot of questions to answer. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Fill out the form below and one of our staff will be in touch. I will be able to go above and beyond the current standard of care to provide cutting-edge and novel testing to pet owners and veterinarians in seven surrounding counties across two states. Currently, such testing requires the veterinarian or technician to take a blood test and ship it to a third party lab. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. The pandemic-fueled pet boom is only going to raise that. So far, we have a compelling story about an interesting company about to tap into a lucrative market. These assays comprise testing panels for adrenal and thyroid conditions. Lower costs and improved efficiency for veterinarians: If Truforma delivers on the promise of improved test accuracy, it could help veterinarians become more competitive in two ways. Offering complete thyroid testing on-site for both dogs and cats will allow our internal medicine service to provide timely answers to anxious pet owners. An attempted reverse stock split was rejected by shareholders. Its the size of a shoebox and weighs in at just seven pounds. Zomedicas product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. Uh-Oh. The launch of the TRUFORMA platform is nearing. All rights reserved. Dr. Berg commented that, As a veterinary internist and business owner, I have devoted myself to advancing the practice of veterinary internal medicine and delivering care with a difference doing more, providing more, and caring more. 100 Phoenix DriveSuite 125Ann Arbor, MI 48108, General inquiries: info@zomedica.comInvestor inquiries: investors@zomedica.com, Privacy Notice | Terms of Use | Supplier Terms & Conditions | Minimum Advertised Pricing | Customer Terms & Conditions | Forward Looking Statements. These symbols will be available throughout the site during your session. Nasdaq Congratulations to Be sure to check out the latest VetBlast podcast on DVM360.com. Zomedica has announced that they will begin commercialization of TRUFORMA on March 30, 2021, and will continue the development of ZM-020 and ZM-017 diagnostic platforms (to diagnose. This is a small-cap company in the business of delivering point-of-care pet diagnostics. Tarform. However, you may visit "Cookie Settings" to provide a controlled consent. Endogenous ACTH and free T4 are expected to be available during the coming weeks. Fill out the form below and well send along some additional materials to help you decide if TRUFORMA is a good fit for your clinic. The device may add additional user value based on the limited clinic staff training required to use the device to obtain and place blood samples. https://www.youtube.com/embed/HDDbf76Ngt4, Do Not Sell My Personal Data/Privacy Policy. I am most excited to use endogenous ACTH in my work as a veterinary internist to help owners make difficult decisions about medical care, including the decision to pursue complex adrenal surgery.. THIS IS SIGNIFICANT and could result in a very quick ROI for the vet offices. For more information, visit www.ZOMEDICA.com. Zomedicas product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health.

Dark Magician Original Art, Articles W